- Filed
- May 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 31, 2025 | 1.06B sh |
| Short Term Investments | FY 2025 · Mar 31, 2024 | $1B |
| Cash And Equivalents | FY 2025 · Mar 31, 2024 | $1.92B |
| Current Liabilities | FY 2025 · Mar 31, 2024 | $1.51B |
| Total Liabilities | FY 2025 · Mar 31, 2024 | $2.63B |
| Current Assets | FY 2025 · Mar 31, 2024 | $4.2B |
| Total Assets | FY 2025 · Mar 31, 2024 | $7.93B |
| Shares Diluted restated | FY 2025 · Mar 31, 2023 | 1.03B sh |
| Capex | FY 2025 · Mar 31, 2023 | $64M |
| Operating Cash Flow | FY 2025 · Mar 31, 2023 | $739M |
| Eps Diluted | FY 2025 · Mar 31, 2023 | $0.51 |
| Eps Basic | FY 2025 · Mar 31, 2023 | $0.51 |
| Sga Expense | FY 2025 · Mar 31, 2023 | $762M |
| Rd Expense | FY 2025 · Mar 31, 2023 | $1.13B |
| Net Income | FY 2025 · Mar 31, 2023 | $524M |
| Operating Income | FY 2025 · Mar 31, 2023 | $671M |
| Gross Profit | FY 2025 · Mar 31, 2023 | $2.57B |
| Cost Of Revenue | FY 2025 · Mar 31, 2023 | $106M |
| Revenue | FY 2025 · Mar 31, 2023 | $2.68B |
| Stockholders Equity | FY 2025 · Mar 31, 2022 | $3.55B |